Lisata Therapeutics (LSTA)

• Market cap: $31.4M
• 1 day: -0.58%
• 5 days: -1.43%
• 1 month: 7.81%
• 3 months: -31.27%
• 6 months: 68.29%
• Year to date: 76.02%
• 1 year: 43.75%
• 5 years: -85.35%
• 10 years: -95.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Employees: 21